Related Experiment Videos
Prognostic factors in microvascular decompression for trigeminal neuralgia
Neurosurgery
|December 1, 1985
Summary
Microvascular decompression (MVD) offers a high cure rate for trigeminal neuralgia (TN) patients with paroxysmal pain only. Prognosis is less favorable for those with permanent pain components, influenced by pain distribution and surgical factors.
Area of Science:
- Neurosurgery
- Neurology
Background:
- Trigeminal neuralgia (TN) is a debilitating neuropathic facial pain disorder.
- Microvascular decompression (MVD) is a primary surgical treatment for TN.
- Predicting MVD outcomes is crucial for patient management.
Purpose of the Study:
- To analyze factors influencing microvascular decompression (MVD) outcomes in trigeminal neuralgia (TN).
- To identify prognostic indicators for MVD success in different TN presentations.
Main Methods:
- Retrospective analysis of 68 patients undergoing MVD for TN.
- Evaluation of 20 clinical and operative factors.
- Follow-up duration of 1 to 5 years.
Main Results:
- Pain manifestation type is the strongest predictor of MVD success (p < 0.001).
- 95% cure rate for paroxysmal pain only vs. 58% for paroxysmal and permanent pain.
- Factors like pain distribution, sensory deficit, prior surgery, and VNC severity/site impact outcomes in patients with permanent pain.
Conclusions:
- MVD is highly effective for TN with exclusively paroxysmal pain.
- Prognosis for TN with permanent pain components is influenced by specific clinical and operative factors.
- Distinguishing TN clinical forms is essential for accurate prognostication and treatment planning.